As of April 30, 2025, Vincerx Pharma (VINC) has a market cap of $298,353 Dollars USD. According to our data, Vincerx Pharma is ranked No.9287 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 30, 2025 | $298,353 Dollars |
-97.47%
|
Dec 31, 2024 | $11.78 M |
-77.71%
|
Dec 29, 2023 | $52.85 M |
15.69%
|
Dec 30, 2022 | $45.69 M |
-89.99%
|
Dec 31, 2021 | $0.46 B |
-51.27%
|
Dec 31, 2020 | $0.94 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() ADC Therapeutics
ADCT
|
$0.14 B |
-0.000 M
|
![]() Switzerland
|
![]() Mersana Therapeutics
MRSN
|
$46.04 M |
0.000 M
|
![]() USA
|
![]() Sutro Biopharma
STRO
|
$73.28 M |
0.000 M
|
![]() USA
|
![]() Zymeworks
ZYME
|
$0.88 B |
-0.000 M
|
![]() Canada
|
![]() BioAtla
BCAB
|
$28.94 M |
0.007 M
|
![]() USA
|
![]() Nektar Therapeutics
NKTR
|
$0.14 B |
-0.000 M
|
![]() USA
|
![]() CytomX Therapeutics
CTMX
|
$52.19 M |
-0.000 M
|
![]() USA
|
![]() Pieris Pharmaceuticals
PIRS
|
$17.96 M |
0.000 M
|
![]() USA
|
Market Cap | = | VINC Stock Price | * | VINC Shares Outstanding |
= | $0.06 | * | 5.23 M | |
= | $298,353 Dollars |